Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Leukemia and KIR2DL5A[original query] |
---|
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia. Experimental hematology 2012 Nov 40 (11): 906-913.e1. Kreutzman Anna, Jaatinen Taina, Greco Dario, Vakkila Emmi, Richter Johan, Ekblom Marja, Hjorth-Hansen Henrik, Stenke Leif, Melo Teresa, Paquette Ron, Seggewiss-Bernhardt Ruth, Guerci-Bresler Agnés, Talbot Alexis, Cayuela Jean Michel, Mahon Francois-Xavier, Porkka Kimmo, Lipton Jeff, Partanen Jukka, Rousselot Philippe, Mustjoki Sa |
Donor KIR Genotype Impacts on Clinical Outcome after T Cell-Depleted HLA Matched Related Allogeneic Transplantation for High-Risk Pediatric Leukemia Patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 8 24 (12): 2493-2500. Escudero Adela, Martínez-Romera Isabel, Fernández Lucía, Valentín Jaime, González-Vicent Marta, Vicario José Luis, Madero-Jarabo Rosario, Diaz Miguel Ángel, Pérez-Martínez Anton |
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Turkish journal of haematology : official journal of Turkish Society of Haematology 2019 Jul . Varbanova Viktoria Plamenova, Mihailova Snejina, Naumova Elissaveta, Mihaylova Anastasiya Petro |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: